Biohaven (BHVN) News Today $44.39 -4.27 (-8.78%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Biohaven stock target cut by analyst on model updatesNovember 15 at 11:17 PM | uk.investing.comBiohaven Ltd. (BHVN) Receives a Buy from Morgan StanleyNovember 15 at 11:17 PM | markets.businessinsider.comBiohaven (NYSE:BHVN) Shares Down 8% - Here's What HappenedBiohaven (NYSE:BHVN) Stock Price Down 8% - Here's WhyNovember 15 at 3:22 PM | marketbeat.comAandelen Biohaven stijgen na verhoging koersdoel door TD Cowen naar $75November 14 at 3:44 PM | nl.investing.comBiohaven Ltd.: Promising Prospects and Financial Stability Drive Buy RatingNovember 14 at 3:44 PM | markets.businessinsider.comBiohaven Ltd.: Strong Buy Rating Driven by Promising Pipeline Progress and Strategic ResubmissionsNovember 14 at 3:44 PM | markets.businessinsider.comBiohaven's (BHVN) "Buy" Rating Reiterated at HC WainwrightHC Wainwright restated a "buy" rating and issued a $59.00 target price on shares of Biohaven in a research note on Thursday.November 14 at 8:31 AM | marketbeat.comRoyal Bank of Canada Lowers Biohaven (NYSE:BHVN) Price Target to $66.00Royal Bank of Canada lowered their target price on shares of Biohaven from $68.00 to $66.00 and set an "outperform" rating on the stock in a report on Wednesday.November 13, 2024 | marketbeat.comBiohaven Ltd.: Biohaven Reports Third Quarter 2024 Financial Results and Recent Business DevelopmentsNovember 13, 2024 | finanznachrichten.deBiohaven Ltd.’s Strategic Advancements and Promising Pipeline Drive Buy RatingNovember 13, 2024 | markets.businessinsider.comBiohaven Reports Third Quarter 2024 Financial Results and Recent Business DevelopmentsNovember 12, 2024 | prnewswire.comBiohaven options imply 19.6% move in share price post-earningsNovember 12, 2024 | markets.businessinsider.comSpiderRock Advisors LLC Acquires New Holdings in Biohaven Ltd. (NYSE:BHVN)SpiderRock Advisors LLC purchased a new position in Biohaven Ltd. (NYSE:BHVN - Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 12,400 shares of the company's stock, valued at approximately $620,000. A number of other heNovember 11, 2024 | marketbeat.comBiohaven Ltd. (NYSE:BHVN) Given Average Recommendation of "Buy" by AnalystsShares of Biohaven Ltd. (NYSE:BHVN - Get Free Report) have been assigned an average recommendation of "Buy" from the fourteen ratings firms that are presently covering the firm, Marketbeat reports. Thirteen equities research analysts have rated the stock with a buy recommendation and one has givenNovember 7, 2024 | marketbeat.comCantor Fitzgerald Reaffirms "Overweight" Rating for Biohaven (NYSE:BHVN)Cantor Fitzgerald reaffirmed an "overweight" rating on shares of Biohaven in a report on Wednesday.October 23, 2024 | marketbeat.comCadent Capital Advisors LLC Takes $1.77 Million Position in Biohaven Ltd. (NYSE:BHVN)Cadent Capital Advisors LLC bought a new position in shares of Biohaven Ltd. (NYSE:BHVN - Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 35,449 shares of the company's stock, valued at appOctober 20, 2024 | marketbeat.comLeerink Partnrs Predicts Biohaven's Q3 Earnings (NYSE:BHVN)Biohaven Ltd. (NYSE:BHVN - Free Report) - Stock analysts at Leerink Partnrs dropped their Q3 2024 earnings per share (EPS) estimates for Biohaven in a research report issued on Tuesday, October 15th. Leerink Partnrs analyst M. Goodman now anticipates that the company will post earnings per shareOctober 18, 2024 | marketbeat.comShort Interest in Biohaven Ltd. (NYSE:BHVN) Decreases By 10.1%Biohaven Ltd. (NYSE:BHVN - Get Free Report) saw a significant drop in short interest during the month of September. As of September 30th, there was short interest totalling 8,980,000 shares, a drop of 10.1% from the September 15th total of 9,990,000 shares. Based on an average daily volume of 1,020,000 shares, the days-to-cover ratio is currently 8.8 days.October 17, 2024 | marketbeat.comBofA handhaaft koopadvies voor Biohaven-aandelen, ziet opwaarts potentieel in SMA-studieOctober 15, 2024 | nl.investing.comBiohaven Ltd. (NYSE:BHVN) Given Consensus Recommendation of "Buy" by BrokeragesBiohaven Ltd. (NYSE:BHVN - Get Free Report) has received an average recommendation of "Buy" from the fourteen research firms that are currently covering the stock, Marketbeat.com reports. Thirteen research analysts have rated the stock with a buy rating and one has given a strong buy rating to thOctober 13, 2024 | marketbeat.comBiohaven: A Complicated TaleOctober 12, 2024 | seekingalpha.comBiohaven Ltd. (BHVN) Gets a Buy from Morgan StanleyOctober 12, 2024 | markets.businessinsider.comBuy Rating Affirmed for Biohaven on Promising SMA Treatment and Convenient Administration AdvantageOctober 10, 2024 | markets.businessinsider.comBiohaven Ltd. (NYSE:BHVN) Holdings Lifted by AQR Capital Management LLCAQR Capital Management LLC grew its holdings in shares of Biohaven Ltd. (NYSE:BHVN - Free Report) by 234.3% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 54,361 shares of the company's stock after bOctober 10, 2024 | marketbeat.comBiohaven blijft stabiel met koersdoel van $60 door optimisme over SMA-onderzoekOctober 9, 2024 | nl.investing.comBuy Rating on Biohaven: Breakthrough Potential with T-Alfa in SMA TreatmentOctober 9, 2024 | markets.businessinsider.comSquarepoint Ops LLC Buys New Position in Biohaven Ltd. (NYSE:BHVN)Squarepoint Ops LLC purchased a new position in shares of Biohaven Ltd. (NYSE:BHVN - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 17,064 shares of the company's stock, valued at approximOctober 9, 2024 | marketbeat.comBofA verhoogt koersdoel Biohaven-aandeel na positieve studie-updateOctober 8, 2024 | nl.investing.comBiohaven behoudt koopadvies met koersdoel van $59 te midden van optimisme over SMA-onderzoekOctober 8, 2024 | nl.investing.comBernstein Keeps Their Buy Rating on Biohaven Ltd. (BHVN)October 8, 2024 | markets.businessinsider.comBiohaven (NYSE:BHVN) Stock Price Up 4.9% - Here's What HappenedBiohaven (NYSE:BHVN) Shares Up 4.9% - Still a Buy?October 7, 2024 | marketbeat.comCantor Fitzgerald Reiterates "Overweight" Rating for Biohaven (NYSE:BHVN)Cantor Fitzgerald reissued an "overweight" rating on shares of Biohaven in a research report on Friday.October 4, 2024 | marketbeat.comBiohaven Ltd. (NYSE:BHVN) Director John W. Childs Buys 21,052 SharesOctober 4, 2024 | insidertrades.comStrong Buy Rating for Biohaven Ltd. on Troriluzole’s Market Potential and Robust PipelineOctober 3, 2024 | markets.businessinsider.comBiohaven (NYSE:BHVN) Price Target Raised to $68.00 at JPMorgan Chase & Co.JPMorgan Chase & Co. lifted their price objective on Biohaven from $55.00 to $68.00 and gave the company an "overweight" rating in a research report on Thursday.October 3, 2024 | marketbeat.comBullish Biohaven Insiders Loaded Up On US$41.7m Of StockOctober 3, 2024 | finance.yahoo.comJohn W. Childs Purchases 21,052 Shares of Biohaven Ltd. (NYSE:BHVN) StockBiohaven Ltd. (NYSE:BHVN - Get Free Report) Director John W. Childs bought 21,052 shares of the business's stock in a transaction on Wednesday, October 2nd. The shares were acquired at an average price of $47.50 per share, for a total transaction of $999,970.00. Following the completion of the purchase, the director now owns 21,052 shares in the company, valued at approximately $999,970. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink.October 3, 2024 | marketbeat.comMarshall Wace LLP Sells 677,724 Shares of Biohaven Ltd. (NYSE:BHVN)Marshall Wace LLP lessened its holdings in shares of Biohaven Ltd. (NYSE:BHVN - Free Report) by 86.5% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 105,568 shares of the company's stock after selling 677,724October 3, 2024 | marketbeat.comBiohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional SharesOctober 2, 2024 | prnewswire.comTD Cowen Sticks to Its Buy Rating for Biohaven Ltd. (BHVN)October 2, 2024 | markets.businessinsider.comBiohaven Ltd. (NYSE:BHVN) Shares Sold by Point72 Asset Management L.P.Point72 Asset Management L.P. decreased its position in Biohaven Ltd. (NYSE:BHVN - Free Report) by 80.5% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 177,362 shares of the company's stock after sellOctober 2, 2024 | marketbeat.comBiohaven Announces Pricing Of Public Offering - Quick FactsOctober 1, 2024 | markets.businessinsider.comBiohaven prices $250M share offeringOctober 1, 2024 | msn.comBiohaven (NYSE:BHVN) Sees Strong Trading VolumeBiohaven (NYSE:BHVN) Sees Unusually-High Trading VolumeOctober 1, 2024 | marketbeat.comBiohaven Announces Pricing of $250 Million Public Offering of Common SharesOctober 1, 2024 | prnewswire.comBiohaven Announces Proposed Public Offering of Common SharesSeptember 30, 2024 | prnewswire.comBiohaven Initiates Pivotal Trial of Novel Investigational Drug for Treatment of MigraineSeptember 30, 2024 | prnewswire.comPerceptive Advisors LLC Sells 239,815 Shares of Biohaven Ltd. (NYSE:BHVN)Perceptive Advisors LLC trimmed its position in Biohaven Ltd. (NYSE:BHVN - Free Report) by 13.9% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,485,232 shares of the company's stock after selling 23September 30, 2024 | marketbeat.com97,902 Shares in Biohaven Ltd. (NYSE:BHVN) Purchased by Cubist Systematic Strategies LLCCubist Systematic Strategies LLC bought a new stake in shares of Biohaven Ltd. (NYSE:BHVN - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 97,902 shares of the company's stock, valued at apprSeptember 29, 2024 | marketbeat.comFred Alger Management LLC Has $1.40 Million Stock Holdings in Biohaven Ltd. (NYSE:BHVN)Fred Alger Management LLC reduced its stake in shares of Biohaven Ltd. (NYSE:BHVN - Free Report) by 21.2% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 40,294 shares of the company's stockSeptember 28, 2024 | marketbeat.com Get Biohaven News Delivered to You Automatically Sign up to receive the latest news and ratings for BHVN and its competitors with MarketBeat's FREE daily newsletter. Email Address The Tesla Trade Is Back In Business (Ad)If you held shares of Tesla throughout 2024, you know It’s been a year of extreme highs and lows… But according to our one expert, new yearly highs are on the horizon… In his words, Tesla is building momentum like in 2020, especially as Trump supports the EV maker. Which is why we’re emailing you now… You see, most people will simply buy shares of Tesla ahead of the election… But as they say “There is more than one way to skin a cat” In fact, we’ve found another way to play shares of Tesla. Discover how to trade Tesla, simply follow this link here. BHVN Media Mentions By Week BHVN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BHVN News Sentiment▼0.210.55▲Average Medical News Sentiment BHVN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BHVN Articles This Week▼175▲BHVN Articles Average Week Get Biohaven News Delivered to You Automatically Sign up to receive the latest news and ratings for BHVN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Viatris News Moderna News Genmab A/S News Summit Therapeutics News Dr. Reddy's Laboratories News Vaxcyte News Catalent News Sarepta Therapeutics News Qiagen News Revolution Medicines News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:BHVN) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biohaven Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biohaven With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.